SLSN
SLSN
NASDAQ · Chemicals

Solesence Inc

$0.91
+0.04 (+4.72%)
Financial Highlights (FY 2026)
Revenue
58.74M
Net Income
1.70M
Gross Margin
25.9%
Profit Margin
2.9%
Rev Growth
+18.5%
D/E Ratio
0.87
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 25.9% 25.9% 44.0% 44.0%
Operating Margin 2.5% 2.3% 20.4% 16.3%
Profit Margin 2.9% 2.7% 13.0% 15.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 58.74M 49.58M 30.11M 28.35M
Gross Profit 15.20M 12.83M 13.23M 12.46M
Operating Income 1.49M 1.13M 6.14M 4.63M
Net Income 1.70M 1.29M 3.91M 4.44M
Gross Margin 25.9% 25.9% 44.0% 44.0%
Operating Margin 2.5% 2.3% 20.4% 16.3%
Profit Margin 2.9% 2.7% 13.0% 15.7%
Rev Growth +18.5% +18.5% +8.3% +13.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 14.05M 14.05M 14.89M 14.06M
Total Equity 16.23M 16.23M 59.27M 54.81M
D/E Ratio 0.87 0.87 0.25 0.26
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 2.34M 1.87M 7.35M 6.83M
Free Cash Flow — — 3.76M 3.68M